BSE Live
Jun 02, 16:01Prev. Close
932.15
Open Price
932.05
Bid Price (Qty.)
922.70 (193)
Offer Price (Qty.)
922.70 (7)
NSE Live
Jun 02, 15:59Prev. Close
932.45
Open Price
936.00
Bid Price (Qty.)
922.25 (8)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Gland Pharma (in Rs. Cr.) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 0.00 | 1,619.04 | 1,334.85 | 992.87 | 686.36 | |
Net CashFlow From Operating Activities | 0.00 | 791.29 | 604.93 | 700.94 | 185.06 | |
Net Cash Used In Investing Activities | 0.00 | -1,010.23 | -1,524.55 | -766.08 | -314.14 | |
Net Cash Used From Financing Activities | 0.00 | 34.90 | 1,238.46 | -6.87 | -2.93 | |
Foreign Exchange Gains / Losses | 0.00 | 3.31 | 3.58 | 5.11 | -4.43 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 0.00 | -180.73 | 322.42 | -66.91 | -136.44 | |
Cash And Cash Equivalents Begin of Year | 0.00 | 491.92 | 169.50 | 236.40 | 372.84 | |
Cash And Cash Equivalents End Of Year | 0.00 | 311.18 | 491.92 | 169.50 | 236.40 |
18.05.2023
Gland Standalone March 2023 Net Sales at Rs 785.42 crore, down 28.79% Y-o-Y
18.05.2023
Gland Consolidated March 2023 Net Sales at Rs 785.01 crore, down 28.83% Y-o-Y
23.01.2023
Gland Standalone December 2022 Net Sales at Rs 925.90 crore, down 12.92% Y-o-Y
23.01.2023
Gland Consolidated December 2022 Net Sales at Rs 938.29 crore, down 11.76% Y-o-Y